51
Universal Cancer Vaccine_Cancer
Yale University
Cell therapy
Oncology
Target Identification or Validation
Unlike other vaccine-based technologies, OCR 5120 is not cancer-type specific, but a “panvaccine” antigen.. The human immune system can respond to OCR5120 and identify the specific immunogenic epitopes derived from the OCR5120 antigen (see figure) as a matter of surveillance rather than response.
OCR5120 targets factor that is important in self-renewal and maintenance of pluripotency in embryonic stem cells.
US 9808504 B2